C. Dromain

发表

[Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience].

T. de Baère, M. Ducreux, D. Elias, 1999, Gastroenterologie clinique et biologique.

Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.

A Roche, T. de Baère, M. Ducreux, 2002, AJR. American journal of roentgenology.

Breast elasticity: principles, technique, results: an update and overview of commercially available software.

M. Mathieu, C. Balleyguier, C. Dromain, 2013, European journal of radiology.

Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels.

A. Padhani, C. Balleyguier, D. Vanel, 2009, European journal of radiology.

Breast elastography: the technical process and its applications.

C. Balleyguier, C. Dromain, S. Canale, 2013, Diagnostic and interventional imaging.

Contrast-enhanced digital mammography.

Corinne Balleyguier, Clarisse Dromain, C. Balleyguier, 2009, European journal of radiology.

Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?

Bernd Hamm, Felix Diekmann, Clarisse Dromain, 2014, Breast Cancer Research and Treatment.

Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size

M. Krohn, M. Krohn, K. Winzer, 2013, European Radiology.

Localized Biphasic Malignant Peritoneal Mesothelioma: Two Case Reports in Atypical Location and Literature Review

C. Sempoux, C. Dromain, M. Vermersch, 2021, Annals of Case Reports.

Results of Systematic Second-Look Surgery in Patients at High Risk of Developing Colorectal Peritoneal Carcinomatosis

M. Ducreux, D. Elias, C. Dromain, 2008, Annals of surgery.

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry

S. Msika, F. Guyon, V. Servois, 2017, Orphanet Journal of Rare Diseases.

Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.

T. de Baère, M. Schlumberger, C. Dromain, 2011, Radiology.

Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10%) well-differentiated endocrine carcinoma staging.

T. de Baère, M. Ducreux, E. Baudin, 2011, The Journal of clinical endocrinology and metabolism.

Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy

M. Ducreux, D. Elias, C. Dromain, 2004, Journal of surgical oncology.

Patients Operated On for Initially Unresectable Colorectal Liver Metastases With Missing Metastases Experience a Favorable Long-Term Outcome

M. Ducreux, D. Elias, C. Dromain, 2011, Annals of surgery.

Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation)

T. Baère, M. Pocard, D. Elias, 2005, Annals of Surgical Oncology.

Outcome of Posthepatectomy-Missing Colorectal Liver Metastases after Complete Response to Chemotherapy: Impact of Adjuvant Intra-arterial Hepatic Oxaliplatin

M. Ducreux, D. Elias, C. Dromain, 2007, Annals of Surgical Oncology.

Complete Radiological Response of Colorectal Liver Metastases after Chemotherapy: What Can We Expect?

M. Ducreux, D. Elias, C. Dromain, 2011, Digestive Surgery.

Cancers of the biliary system.

F. Prat, T. de Baère, C. Dromain, 2006, Gastroenterologie clinique et biologique.

MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.

T. de Baère, M. Ducreux, E. Baudin, 2003, AJR. American journal of roentgenology.

Application clinique de la TEP dans la prise en charge du cancer colorectal

C. Dromain, J. Lumbroso, S. Leboulleux, 2005, Oncologie.

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors

A. Fojo, B. Mirakhur, C. Dromain, 2021, The oncologist.

Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experience.

Isabelle Borget, Corinne Balleyguier, Clarisse Dromain, 2012, Academic radiology.

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

T. de Baère, M. Ducreux, E. Baudin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional and Radiological Imaging of Neuroendocrine Neoplasms

John O. Prior, C. Dromain, N. Schaefer, 2020 .

Imaging of neuroendocrine tumors of the pancreas.

M. Ducreux, E. Baudin, J. Scoazec, 2016, Diagnostic and interventional imaging.

Intervention in gastro-enteropancreatic neuroendocrine tumours.

D. Planchard, M. Ducreux, E. Baudin, 2012, Best practice & research. Clinical gastroenterology.

F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients

BorgetIsabelle, E. Baudin, M. Schlumberger, 2019, Thyroid.

Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.

E. Baudin, M. Schlumberger, D. Vanel, 2007, The Journal of clinical endocrinology and metabolism.

The differential response to chemotherapy of ovarian metastases from colorectal carcinoma.

M. Ducreux, M. Pocard, D. Elias, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).

P. Terrier, S. Bonvalot, A. Le Cesne, 2009, European journal of radiology.

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

H. Sorbye, E. Raymond, James C Yao, 2021, Journal of neuroendocrinology.

Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy

B. Denis de Senneville, A. Denys, C. Dromain, 2018, European Radiology.

Radio frequency ablation of renal cell carcinoma: preliminary clinical experience.

T. de Baère, C. Dromain, A. Roche, 2002, The Journal of urology.

Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice

E. Baudin, V. Prasad, C. Dromain, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Histological findings in surgical specimens after core biopsy of the breast.

C. Dromain, A. Tardivon, J. Guinebretière, 2002, European journal of radiology.

Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination: They are Many More Than You Think …

E. Baudin, D. Elias, C. Dromain, 2010, Annals of surgery.

Contrast-enhanced spectral mammography (CESM) in a large scale breast cancer screening program. Preliminary clinical experience.

C. Balleyguier, C. Dromain, A. Loshkajian, 2012 .

Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.

T. de Baère, V. Lazar, J. Soria, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Contrast enhanced spectral mammography: better than MRI?

C. Balleyguier, C. Dromain, A. Tardivon, 2012, European journal of radiology.

Breast Lesion Excision Sample (BLES Biopsy) Combining Stereotactic Biopsy and Radiofrequency: Is it a Safe and Accurate Procedure in Case of BIRADS 4 and 5 Breast Lesions?

M. Mathieu, C. Balleyguier, C. Dromain, 2013, The breast journal.

Intra-abdominal desmoplastic small round cell tumors: CT findings and clinicopathological correlations in 13 cases.

D. Vanel, C. Dromain, K. Fizazi, 2005, European journal of radiology.

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.

M. Ducreux, E. Baudin, P. Rougier, 2014, European journal of cancer.

Bevacizumab in patients (pts) with advanced hepatocellular carcinoma (HCC): Preliminary results of a phase II study with circulating endothelial cell (CEC) monitoring

J. Pignon, M. Ducreux, C. Dromain, 2007 .

Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) : The Greponet Study

M. Ronot, M. Pavel, C. Dromain, 2018 .

Breast pain and imaging.

C. Balleyguier, C. Dromain, S. Delaloge, 2015, Diagnostic and interventional imaging.

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

D. Elias, C. Dromain, P. Duvillard, 2008, The British journal of surgery.

Tumor response assessment on imaging following immunotherapy

R. Duran, C. Dromain, S. Boughdad, 2022, Frontiers in Oncology.

Anatomical noise in contrast-enhanced digital mammography. Part I. Single-energy imaging.

Mehran Ebrahimi, Ann-Katherine Carton, Serge Muller, 2013, Medical physics.

Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.

M. Ducreux, C. Dromain, V. Boige, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis

M. Ducreux, D. Elias, C. Dromain, 2011, Annals of surgery.

Biliary tract neoplasms: update 2003

M. Ducreux, M. Pocard, C. Dromain, 2004, Current opinion in oncology.

Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT

D. Elias, C. Dromain, J. Lumbroso, 2007, Abdominal Imaging.

Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis.

M. Ducreux, D. Elias, C. Dromain, 2013, European journal of cancer.

Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers.

M. Ducreux, D. Elias, C. Dromain, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Abbreviated MRI for Preoperative Assessment of Breast Cancer: is Maximal Intensity Projection (MIP) of the First Post Contrast Acquisition Subtracted (Fast) Sequence Sufficient for Disease Evaluation?

J. Meuwly, C. Dromain, J. Ledoux, 2022, Journal of cancer science and clinical therapeutics.

Estimated Costs of the Ipilimumab–Nivolumab Therapy and Related Adverse Events in Metastatic Melanoma

John O. Prior, M. Cuendet, O. Michielin, 2022, Cancers.

Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion.

Clarisse Dromain, Anne Aupérin, Thierry de Baere, 2008, Radiology.

New potential and applications of contrast-enhanced ultrasound of the breast; own investigations and review of the literature

Corinne Balleyguier, Clarisse Dromain, P. Opolon, 2009 .

New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature.

Corinne Balleyguier, Clarisse Dromain, Alexandra Athanasiou, 2009, European journal of radiology.

Computed Tomographic Features of Peritoneal Carcinomatosis Treated by Intraperitoneal Chemohyperthermia

D. Elias, C. Dromain, P. Lasser, 2003, Journal of computer assisted tomography.

Adverse events during radiofrequency treatment of 582 hepatic tumors.

T. de Baère, C. Létoublon, D. Elias, 2003, AJR. American journal of roentgenology.

Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up.

P. Petrow, T. de Baère, M. Ducreux, 2002, Radiology.

Thyroid metastases from colorectal cancer: the Institut Gustave Roussy experience.

A. Lièvre, M. Ducreux, D. Elias, 2006, European journal of cancer.

Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial.

V. Vilgrain, M. Ducreux, E. Baudin, 2014, European journal of cancer.

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

John O. Prior, Santiago J. Carmona, G. Coukos, 2021, Cancer discovery.

Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.

T. de Baère, M. Ducreux, E. Baudin, 2012, Journal of hepatology.

Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma

John O. Prior, N. Demartines, G. Coukos, 2022, bioRxiv.

Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.

A. Ravaud, T. de Baère, M. Ducreux, 2006, Radiology.

Liposarcoma or lipoma: does genetics change classic imaging criteria?

F. Bidault, P. Terrier, S. Bonvalot, 2009, European journal of radiology.

Heterotopic Gastric Mucosa in a Duplication Cyst of the Common Hepatic Duct Mimicking Cholangiocarcinoma

C. Sempoux, R. Duran, C. Dromain, 2018, International journal of surgical pathology.

Efficacy, safety, and biomarkers of single-agent bevacizumab therapy in patients with advanced hepatocellular carcinoma.

J. Pignon, T. de Baère, M. Ducreux, 2012, The oncologist.

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

W. Oyen, V. Ambrosini, S. Fanti, 2021, European journal of cancer.

Deconvolution technique for measuring tissue perfusion by dynamic CT: application to normal and metastatic liver.

G. Frija, C. Cuénod, N. Siauve, 2002, Academic radiology.

Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT.

F Frouin, G. Frija, C. Cuénod, 2001, Radiology.

Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.

P. Petrow, P. Terrier, S. Bonvalot, 2005, European journal of radiology.

Prognostic parameters of metastatic adrenocortical carcinoma.

E. Baudin, J. Bertherat, X. Bertagna, 2007, The Journal of clinical endocrinology and metabolism.

Imaging of Oligometastatic Disease

C. Dromain, M. Nicod-Lalonde, R. Hajri, 2022, Cancers.

Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

B. Bot, J. Soria, S. Koscielny, 2013, Clinical Cancer Research.

Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma.

P. Chanson, A. Paci, T. de Baère, 2010, Endocrine-related cancer.

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

E. Baudin, P. Ruszniewski, M. Pavel, 2019, BMC Cancer.

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

G. Krejs, B. Kos-Kudła, V. Prasad, 2021, Journal of Neuroendocrinology.

Imaging of Gastric Carcinomatosis

C. Dromain, N. Vietti Violi, Raquel Saiz Martínez, 2021, Journal of clinical medicine.

Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability

M. Ronot, M. Pavel, C. Dromain, 2020, Neuroendocrinology.

The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor

J. Knebel, R. Duran, C. Dromain, 2020, European Radiology.

Imaging of tumour response to immunotherapy

C. Beigelman, R. Duran, C. Dromain, 2020, European Radiology Experimental.

First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver

J. Knebel, R. Duran, O. Michielin, 2020, The Journal of Nuclear Medicine.

Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study

M. Ronot, E. Baudin, M. Pavel, 2019, Clinical Cancer Research.

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

M. Ronot, M. Pavel, C. Dromain, 2019, The oncologist.

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol

T. de Baère, C. Dromain, V. Boige, 2020, BMC Cancer.

Infantile fibrosarcoma: magnetic resonance imaging findings in six cases.

D. Vanel, C. Patte, C. Dromain, 2009, European journal of radiology.

Imaging assessment of toxicity related to immune checkpoint inhibitors

R. Duran, C. Dromain, V. Dunet, 2023, Frontiers in Immunology.

Computed-aided diagnosis (CAD) in the detection of breast cancer.

C. Balleyguier, C. Dromain, S. Delaloge, 2013, European journal of radiology.

Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer

R. Marienfeld, N. Fleshner, V. Prasad, 2021, Cancers.

Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art.

J. Scoazec, R. Guimbaud, C. Dromain, 2013, Endocrine-related cancer.

Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma.

T. de Baère, M. Ducreux, E. Baudin, 2009, Endocrine-related cancer.

MR imaging in the evaluation of isolated limb perfusion: a prospective study of 18 cases

P. Petrow, S. Bonvalot, D. Vanel, 2004, Skeletal Radiology.

Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas

M. Ducreux, E. Baudin, M. Schlumberger, 2007, Cancer.

Imaging and management of nonpalpable lesions of the breast.

D. Vanel, C. Dromain, A. Tardivon, 2002, European journal of radiology.

[Radiologic-pathologic correlations in breast diseases].

C. Dromain, A. Tardivon, J. Guinebretière, 2002, Journal de radiologie.

Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome: initial experience.

T. de Baère, M. Ducreux, C. Dromain, 2005, Radiology.

BIRADS classification in mammography.

Daniel Vanel, Corinne Balleyguier, Clarisse Dromain, 2007, European journal of radiology.

Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.

T. de Baère, M. Ducreux, V. Marteau, 2000, AJR. American journal of roentgenology.

MRI of bone marrow disorders

D. Vanel, C. Dromain, A. Tardivon, 2000, European Radiology.

Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.

E. Baudin, M. Schlumberger, C. Dromain, 2008, European journal of endocrinology.

[Biology and imaging of neuroendocrine tumors].

E. Baudin, C. Dromain, 2002, La Revue du praticien.

Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence: A Comparative Study Between Hepatic Arterial Infusion of Oxaliplatin and Modern Systemic Chemotherapy

T. de Baère, M. Ducreux, D. Elias, 2013, Annals of surgery.

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic.

M. Mathieu, F. André, C. Balleyguier, 2016, European journal of cancer.

Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy.

Cyrus Chargari, F. Bidault, C. Balleyguier, 2011, Gynecologic oncology.

BIRADSTM classification in mammography

Daniel Vanel, Corinne Balleyguier, Clarisse Dromain, 2007 .

Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei.

M. Ducreux, D. Elias, C. Dromain, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography.

Serge Muller, Clarisse Dromain, Marie-Christine Mathieu, 2006, AJR. American journal of roentgenology.

Chromogranin a Measurement in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma: Screening for False Positives and a Prospective Follow-Up Study

M. Ducreux, E. Baudin, C. Lombard-Bohas, 2011, The International journal of biological markers.

Are we reproducible in measurement of NET liver metastasis?

D. Planchard, M. Ducreux, N. Ternès, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Diagnostic Performance of MR‐guided Vacuum‐Assisted Breast Biopsy: 8 Years of Experience

M. Mathieu, C. Balleyguier, C. Dromain, 2016, The breast journal.

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.

M. Mathieu, F. André, C. Balleyguier, 2010, Clinical breast cancer.

Contrast-enhanced spectral mammography vs. mammography and MRI – clinical performance in a multi-reader evaluation

B. Hamm, U. Bick, R. Mann, 2017, European Radiology.

Interest of diffusion‐weighted echo‐planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: A review

Corinne Balleyguier, Clarisse Dromain, Caroline Caramella, 2011, Journal of magnetic resonance imaging : JMRI.

Added Value of Contrast‐Enhanced Spectral Mammography in Postscreening Assessment

M. Mathieu, C. Balleyguier, A. Dunant, 2016, The breast journal.

Digital breast tomosynthesis versus mammography and breast ultrasound: a multireader performance study

C. Balleyguier, C. Dromain, A. Tardivon, 2013, European Radiology.

Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure

M. Ducreux, T. Baère, M. Pocard, 2007, Annals of Surgical Oncology.

Intraductal cooling of the main bile ducts during radiofrequency ablation prevents biliary stenosis.

T. de Baère, M. Pocard, D. Elias, 2004, Journal of the American College of Surgeons.

Angiomammography: A review of current evidences.

C. Dromain, J. Meuwly, N. Vietti-Violi, 2019, Diagnostic and interventional imaging.

Tumour growth rates and RECIST criteria in early drug development.

F. Bidault, J. Soria, S. Koscielny, 2011, European Journal of Cancer.

Added value of Virtual Touch IQ shear wave elastography in the ultrasound assessment of breast lesions.

Alexandru Blidaru, Corinne Balleyguier, Clarisse Dromain, 2014, European journal of radiology.

Combining imaging and laparoscopy for the staging of peritoneal metastases: A retrospective cohort pilot study

N. Demartines, M. Hübner, C. Dromain, 2021 .

Whole body MRI in paediatric oncology.

F. Bidault, C. Dromain, C. Caramella, 2014, Diagnostic and interventional imaging.

Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study

Felix Diekmann, Clarisse Dromain, Marcia Koomen, 2012, Breast Cancer Research.

Liposarcoma or lipoma: Imaging and genetic analyses

F. Bidault, S. Bonvalot, D. Vanel, 2010 .

Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib.

L. Trinquart, G. Chatellier, C. Cuénod, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Modeling tumor size dynamics based on real‐world electronic health records and image data in advanced melanoma patients receiving immunotherapy

John O. Prior, K. Venkatakrishnan, M. Cuendet, 2023, CPT: pharmacometrics & systems pharmacology.

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST

M. Mayerhoefer, A. Colao, A. Faggiano, 2023, Journal of neuroendocrinology.

First-in-man study of E-3810, a novel VEGFR and FGFR inhibitor, in patients with advanced solid tumors.

M. Zucchetti, F. D. De Braud, M. Bellomi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable? What should the radiologist know.

M. Ducreux, C. Dromain, C. Caramella, 2014, Diagnostic and interventional imaging.

Phase I/II study of the association of sorafenib and temozolomide (extended schedule) in patients with metastatic melanoma: A new clinical response profile with massive tumor necroses.

L. Zitvogel, V. Lazar, J. Soria, 2009, Journal of Clinical Oncology.

Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases

T. de Baère, M. Ducreux, D. Elias, 2010, Annals of surgery.

Infantile fibrosarcoma: magnetic resonance imaging findings in six cases

D. Vanel, C. Patte, C. Dromain, 2010 .

Dual-energy contrast-enhanced digital mammography: initial clinical results

Serge Muller, Corinne Balleyguier, Clarisse Dromain, 2011, European Radiology.

Dual-energy contrast-enhanced spectral mammography (CESM)

Werner Jaschke, Clarisse Dromain, Christian Marth, 2015, Archives of Gynecology and Obstetrics.

The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening

C. Dromain, Gibran Manasseh, M. Fraga, 2023, European Radiology.

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours

V. Ambrosini, C. Dromain, J. Ramage, 2023, Journal of neuroendocrinology.

Circulating endothelial cells (CEC) and angiogenic proteins monitoring in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with bevacizumab.

J. Pignon, M. Ducreux, C. Dromain, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison Between the Minimum Margin Defined on Preoperative Imaging and the Final Surgical Margin After Hepatectomy for Cancer: How to Manage It?

D. Elias, C. Dromain, N. Lassau, 2008, Annals of Surgical Oncology.

Esophageal cancer T-staging on MRI: A preliminary study using cine and static MR sequences.

C. Dromain, J. Ledoux, Mario Jreige, 2023, European journal of radiology.

Optimization of contrast-enhanced spectral mammography depending on clinical indication

Ann-Katherine Carton, Serge Muller, Sylvie Saab-Puong, 2014, Journal of medical imaging.

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

T. de Baère, T. Baère, E. Baudin, 2010, European journal of endocrinology.

Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.

E. Baudin, B. Caillou, M. Schlumberger, 2006, The Journal of clinical endocrinology and metabolism.

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours

G. Krejs, B. Kos-Kudła, V. Prasad, 2021, Journal of neuroendocrinology.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .

How the rare see their care: Perceptions of care and patient reported outcomes in people living with neuroendocrine tumours

M. Ronot, C. Dromain, A. Sundin, 2018 .

First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer

John O. Prior, C. Dromain, K. Homicsko, 2022, Journal for ImmunoTherapy of Cancer.

Response heterogeneity as a new biomarker of treatment response in patients with neuroendocrine tumors.

M. Ronot, S. Jégou, M. Pavel, 2023, Future Oncology.

Chemoembolization for liver metastases from medullary thyroid carcinoma.

T. de Baère, E. Baudin, M. Schlumberger, 2006, The Journal of clinical endocrinology and metabolism.

F-18-Dopa PET/CT is more sensitive than whole body MRI for the localization of persistent/recurrent disease of medullary thyroid cancer patients.

E. Baudin, M. Schlumberger, C. Dromain, 2019, Thyroid.

Preoperative hiatal hernia in esophageal adenocarcinoma; does it have an impact on patient outcomes?

M. Schäfer, N. Demartines, A. Schoepfer, 2023, Surgical oncology.

P1-123: Response of atypical pulmonary carcinoid tumors to chemotherapy. A retrospective study of 37 patients.

M. Ducreux, T. Baère, E. Baudin, 2007 .

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

T. de Baère, M. Ducreux, T. Baère, 2004, European journal of cancer.

Endocrine pancreatic tumours: which are the most useful MRI sequences?

T. Baère, E. Baudin, M. Schlumberger, 2010, European Radiology.

Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.

E. Baudin, M. Schlumberger, C. Dromain, 2008, Journal of Clinical Endocrinology and Metabolism.